CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer.
about
Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via up-regulating the expression of miR-194-5p and miR-122.ALK1Fc Suppresses the Human Prostate Cancer Growth in in Vitro and in Vivo Preclinical Models.Store-Operated Ca2+ Entry as a Prostate Cancer Biomarker — a Riddle with Perspectives.Suppression of GRP78 sensitizes human colorectal cancer cells to oxaliplatin by downregulation of CD24.
P2860
CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
CRIPTO and its signaling partn ...... n osteotropic prostate cancer.
@en
type
label
CRIPTO and its signaling partn ...... n osteotropic prostate cancer.
@en
prefLabel
CRIPTO and its signaling partn ...... n osteotropic prostate cancer.
@en
P2093
P2860
P50
P356
P1433
P1476
CRIPTO and its signaling partn ...... an osteotropic prostate cancer
@en
P2093
E Snaar-Jagalska
F La Manna
G J L H van Leenders
G van der Pluijm
P2860
P2888
P304
P356
10.1038/ONC.2017.87
P407
P577
2017-04-10T00:00:00Z
P6179
1084764067